TickerFacts.

AtriCure, Inc. (ATRC): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2010-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$48.28M
Year ended 2025-12-31
$53.11M
Trailing 12 months to 2026-06-30
2009-12-31: -$940.5K2010-12-31: -$1.85M2011-12-31: -$3.51M2012-12-31: -$4.92M2013-12-31: -$8.09M2014-12-31: -$27.11M2015-12-31: -$21.29M2016-12-31: -$22.81M2017-12-31: -$15.33M2018-12-31: -$10.38M2019-12-31: -$27.99M2020-12-31: -$25.13M2021-12-31: -$23.53M2022-12-31: -$39.02M2023-12-31: -$7.51M2024-12-31: $745.0K2025-12-31: $48.28M$48.28M
2009-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31$48.28Mn/m2026-02-19, From 2025-01-01
2024-12-31$745.0Kn/m2026-02-19, From 2024-01-01
2023-12-31-$7.51Mn/m2026-02-19, From 2023-01-01
2022-12-31-$39.02Mn/m2025-02-14, From 2022-01-01
2021-12-31-$23.53Mn/m2024-02-16, From 2021-01-01
2020-12-31-$25.13Mn/m2023-02-22, From 2020-01-01
2019-12-31-$27.99Mn/m2022-02-17, From 2019-01-01
2018-12-31-$10.38Mn/m2021-02-26, From 2018-01-01
2017-12-31-$15.33Mn/m2020-02-24, From 2017-01-01
2016-12-31-$22.81Mn/m2019-03-01, From 2016-01-01
2015-12-31-$21.29Mn/m2018-02-28, From 2015-01-01
2014-12-31-$27.11Mn/m2017-03-08, From 2014-01-01
2013-12-31-$8.09Mn/m2016-02-29, From 2013-01-01
2012-12-31-$4.92Mn/m2015-03-02, From 2012-01-01
2011-12-31-$3.51Mn/m2014-03-11, From 2011-01-01
2010-12-31-$1.85Mn/c2013-03-08, From 2010-01-01
2009-12-31-$940.5Kn/a2012-03-12, From 2009-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
AtriCure, Inc. (ATRC)2025-12-31$48.28Mn/m
Glaukos Corp (GKOS)2025-12-31-$22.45Mn/m
Bioventus Inc. (BVS)2025-12-31$72.11M+90.8%
UFP Technologies Inc (UFPT)2024-12-31$56.94M+84.6%
Artivion, Inc. (AORT)2025-12-31$839.0K-92.4%
NovoCure Ltd (NVCR)2025-12-31-$75.68Mn/m
Accuray Inc (ARAY)2026-06-30-$12.84Mn/m
iRhythm Holdings, Inc. (IRTC)2025-12-31$34.52Mn/m
Alphatec Holdings, Inc. (ATEC)2025-12-31$2.78Mn/m

Compare ATRC, GKOS, BVS, UFPT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗